Efficacy and safety of cyclosporine a combined with acitretin in moderate-to-severe plaque psoriasis: a randomized controlled trial
BackgroundDespite the efficacy of biologics in psoriasis treatment, their contraindications limit accessibility. Traditional systemic agents like cyclosporine A (CsA) and acitretin remain first-line options for long-term management, yet evidence on their combined use is scarce.MethodsIn this randomi...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2025-09-01
|
| Seri Bilgileri: | Frontiers in Medicine |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1667058/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|